Magnetic nanoparticles (MNPs) are attractive materials that serve as a support for enzyme immobilization and facilitate separations by applying an external magnetic field; this could facilitate the recycling of enzymes and broaden their applications in organic synthesis. Herein, we report the methods for the immobilization of water-soluble and membrane-bound enzymes, and the activity difference between free and immobilized enzymes is discussed. Sialyltransferase (PmST1, from Pasteurella multocida ) and cytidine monophosphate (CMP)-sialic acid synthetase (CSS, from Neisseria meningitides ) were chosen as water-soluble enzymes and expressed using an intein expression system. The enzymes were site-specifically and covalently immobilized on PEGylated-N-terminal cysteine MNPs through native chemical ligation (NCL). Increasing the length of the PEG linker between the enzyme and the MNP surface increased the activity of the immobilized enzymes relative to the free parent enzymes. In addition, the use of a fluorescent acceptor tag for PmST1 affected enzyme kinetics. In contrast, sialyltransferase from Neisseria gonorrheae (NgST, a membrane-bound enzyme) was modified with a biotin-labeled cysteine at the C-terminus using NCL, and the enzyme was then assembled on streptavidin-functionalized MNPs. Using a streptavidin-biotin interaction, it was possible to immobilize NgST on a solid support under mild ligation conditions, which prevented the enzyme from high-temperature decomposition and provided an approximately 2-fold increase in activity compared to other immobilization methods on MNPs. Finally, the ganglioside GM3-derivative (sialyl-lactose derivative) was synthesized in a one-pot system by combining the use of immobilized PmST1 and CSS. The enzymes retained 50% activity after being reused ten times. Furthermore, the results obtained using the one-pot two-immobilized-enzyme system demonstrated that it can be applied to large-scale reactions with acceptable yields and purity. These features make enzyme-immobilized MNPs applicable to organic synthesis.

No abstract

A straightforward method for fabricating a stable and covalent carbohydrate microarray based on boronate formation between the hydroxyl groups of carbohydrate and boronic acid (BA) on the glass surface was used to identify carbohydrate-protein interactions.

Structural variants of α-galactosylceramide (α-GalCer) that stimulate invariant natural killer T (iNKT) cells constitute an emerging class of immunomodulatory agents in development for numerous biological applications. Variations in lipid chain length and/or fatty acids in these glycoceramides selectively trigger specific pro-inflammatory responses. Studies that would link a specific function to a structurally distinct α-GalCer rely heavily on the availability of homogeneous and pure materials. To address this need, we report herein a general route to the diversification of the ceramide portion of α-GalCer glycolipids. Our convergent synthesis commences from common building blocks and relies on the Julia–Kocienski olefination as a key step. A cleavable fluorous tag is introduced at the non-reducing end of the sugar that facilitates quick purification of products by standard fluorous solid-phase extraction. The strategy enabled the rapid generation of a focused library of 61 α-GalCer analogs by efficiently assembling various lipids and fatty acids. Furthermore, when compared against parent α-GalCer in murine cells, many of these glycolipid variants were found to have iNKT cell stimulating activity similar to or greater than KRN7000. ELISA assaying indicated that glycolipids carrying short fatty N-acyl chains (1fc and 1ga), an unsubstituted (1fh and 1fi) or CF3-substituted phenyl ring at the lipid tail, and a flexible, shorter fatty acyl chain with an aromatic ring (1ge, 1gf, and 1gg) strongly affected the activation of iNKT cells by the glycolipid-loaded antigen-presenting molecule, CD1d. This indicates that the method may benefit the design of structural modifications to potent iNKT cell-binding glycolipids.

Alterations in carbohydrate epitopes present on the cell surface are often hallmark of the transition from normal to neoplastic tissue. The concept of using carbohydrate antigens as cancer marker has thus spurred intense research interests into exploiting TACAs for the development of anticancer vaccines. This study presents a novel carrier protein containing a binding domain to the receptor of antigen presenting cells (APC) and cysteine-rich repeat peptide to serve as docking sites for conjugating tumor associated carbohydrate antigens (TACAs) or haptens. This novel carrier protein after conjugation with Tn, (GalNAcα1-O-Ser/Thr), can effectively elicit high titer of IgG1 antibody rather than IgM against Tn with high specificity in immunized mice. We then performed immunohistochemical (IHC) staining of twenty-six prostate cancer samples by staining with anti-Tn antibody, and we observed that the IHC staining with anti-Tn antibody is proportional to the malignancy of prostate cancer. Furthermore, we have examined the anti-Tn vaccine potency in Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP) mice. TRMAP mice, which were treated with anti-Tn vaccine, showed longer survival rate and delayed tumor growth. We also successfully constructed the cDNA of mouse anti-Tn antibody from hybridoma cell line, and engineer this mouse cDNA as single-chain anti-Tn mouse antibody and anti-Tn immunotoxin. Our preliminary results showed that anti-Tn single-chain antibody can as a diagnostic antibody to distinguish normal prostatic tissue and prostate cancer, and anti-Tn immunotoxin can inhibit tumor cell growth. This study presents that our carrier protein can offer a platform for designing vaccine against tumor-associated weak immunogen and applies a new strategy in cancer immunotherapy in future. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 2533. doi:1538-7445.AM2012-2533